Skip to content

Clinical trials

Glioma trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Country / region: Russia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20171
20192
20224
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Recruiting3
Completed2
Suspended2
No longer available1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sklifosovsky Institute of Emergency Care5
Novartis Pharmaceuticals2
Blokhin's Russian Cancer Research Center1
Center Trials & Treatment1
Isarna Therapeutics GmbH1
Novosibirsk State University1
Tomsk National Research Medical Center of the Russian Academy of Sciences1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma12
Brain Neoplasms6
Glioblastoma6
Astrocytoma4
Ganglioglioma2
Ganglioneuroma2
Meningioma2
Neoplasms2
Neurocytoma2
Oligodendroglioma2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.